Common Contracts

National Vision Holdings, Inc. 12,500,000 Shares Common Stock ($0.01 par value) Underwriting Agreement

National Vision Holdings, Inc. • November 19th, 2018 • Ophthalmic goods • New York

• Company
  National Vision Holdings, Inc.
• Filed
  November 19th, 2018
• Industry
  Ophthalmic goods
• Jurisdiction
  New York

Each of (i) KKR Vision Aggregator L.P. (the “KKR Selling Stockholder”), (ii) Berkshire Fund VI, Limited Partnership, Berkshire Investors LLC and Berkshire Investors III LLC (collectively, the “Berkshire Selling Stockholders”) and (iii) the other selling stockholder named on Schedule I(B) hereto (the “Management Selling Stockholder” and together with the KKR Selling Stockholder and the Berkshire Selling Stockholders, the “Selling Stockholders”), as a stockholder of National Vision Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I(A) hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), set forth next to such Selling Stockholder’s name on Schedule I(B) hereto. The aggregate 12,500,000 Shares to be sold by the Selling Stockholders are herein called the “Securities”).

National Vision Holdings, Inc. 14,447,698 Shares Common Stock ($0.01 par value) Underwriting Agreement

National Vision Holdings, Inc. • July 30th, 2018 • Ophthalmic goods • New York

• Company
  National Vision Holdings, Inc.
• Filed
  July 30th, 2018
• Industry
  Ophthalmic goods
• Jurisdiction
  New York

Each of (i) KKR Vision Aggregator L.P. (the “KKR Selling Stockholder”), (ii) Berkshire Fund VI, Limited Partnership, Berkshire Investors LLC and Berkshire Investors III LLC (collectively, the “Berkshire Selling Stockholders”) and (iii) the other selling stockholders named on Schedule I(B) hereto (collectively, the “Management Selling Stockholders” and together with the KKR Selling Stockholder and the Berkshire Selling Stockholders, the “Selling Stockholders”), as a stockholder of National Vision Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I(A) hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), set forth next to such Selling Stockholder’s name on Schedule I(B) hereto. The aggregate 14,447,698 Shares to be sold by the Selling Stockholders are herein called the

National Vision Holdings, Inc. [ ● ] Shares Common Stock ($0.01 par value) Underwriting Agreement

National Vision Holdings, Inc. • July 23rd, 2018 • Ophthalmic goods • New York

• Company
  National Vision Holdings, Inc.
• Filed
  July 23rd, 2018
• Industry
  Ophthalmic goods
• Jurisdiction
  New York

Each of (i) KKR Vision Aggregator L.P. (the “KKR Selling Stockholder”), (ii) Berkshire Fund VI, Limited Partnership, Berkshire Investors LLC and Berkshire Investors III LLC (collectively, the “Berkshire Selling Stockholders”) and (iii) the other selling stockholders named on Schedule I(B) hereto (collectively, the “Management Selling Stockholders” and together with the KKR Selling Stockholder and the Berkshire Selling Stockholders, the “Selling Stockholders”), as a stockholder of National Vision Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I(A) hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), set forth next to such Selling Stockholder’s name on Schedule I(B) hereto. The aggregate [ ● ] Shares to be sold by the Selling Stockholders are herein called the “Und

National Vision Holdings, Inc. 12,000,000 Shares Common Stock ($0.01 par value) Underwriting Agreement

National Vision Holdings, Inc. • March 19th, 2018 • Ophthalmic goods • New York

• Company
  National Vision Holdings, Inc.
• Filed
  March 19th, 2018
• Industry
  Ophthalmic goods
• Jurisdiction
  New York

Each of (i) KKR Vision Aggregator L.P. (the “KKR Selling Stockholder”), (ii) Berkshire Fund VI, Limited Partnership, Berkshire Investors LLC and Berkshire Investors III LLC (collectively, the “Berkshire Selling Stockholders”) and (iii) the other selling stockholders named on Schedule I(B) hereto (collectively, the “Management Selling Stockholders” and together with the KKR Selling Stockholder and the Berkshire Selling Stockholders, the “Selling Stockholders”), as a stockholder of National Vision Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I(A) hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), set forth next to such Selling Stockholder’s name on Schedule I(B) hereto. The aggregate 12,000,000 Shares to be sold by the Selling Stockholders are herein called the

Underwriting Agreement

National Vision Holdings, Inc. • March 12th, 2018 • Ophthalmic goods • New York

• Company
  National Vision Holdings, Inc.
• Filed
  March 12th, 2018
• Industry
  Ophthalmic goods
• Jurisdiction
  New York

Each of (i) KKR Vision Aggregator L.P. (the “KKR Selling Stockholder”), (ii) Berkshire Fund VI, Limited Partnership, Berkshire Investors LLC and Berkshire Investors III LLC (collectively, the “Berkshire Selling Stockholders”) and (iii) the other selling stockholders named on Schedule I(B) hereto (collectively, the “Management Selling Stockholders” and together with the KKR Selling Stockholder and the Berkshire Selling Stockholders, the “Selling Stockholders”), as a stockholder of National Vision Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I(A) hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (“Common Stock”), set forth next to such Selling Stockholder’s name on Schedule I(B) hereto. The aggregate [ ● ] Shares to be sold by the Selling Stockholders are herein called the “Und

Gardner Denver Holdings, Inc. 22,000,000 Shares Common Stock ($0.01 par value) Underwriting Agreement

Gardner Denver Holdings, Inc. • November 20th, 2017 • General industrial machinery & equipment • New York

• Company
  Gardner Denver Holdings, Inc.
• Filed
  November 20th, 2017
• Industry
  General industrial machinery & equipment
• Jurisdiction
  New York

Each of (i) KKR Renaissance Aggregator L.P. (the “KKR Selling Stockholder”), and (ii) the other selling stockholders named on Schedule I(B) hereto (collectively, the “Management Selling Stockholders” and together with the KKR Selling Stockholder, the “Selling Stockholders”), as a stockholder of Gardner Denver Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several underwriters named in Schedule I(A) hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, the number of shares of the Company’s Common Stock, par value $0.01 per share (the “Shares”) set forth next to such Selling Stockholder’s name on Schedule I(B) hereto. The aggregate 22,000,000 Shares to be sold by the Selling Stockholders are called the “Underwritten Securities”. The KKR Selling Stockholder also proposes to grant to the Underwriters an option to purchase up to 3,300,000 additional shares of Common Stock (the “Option Securities”; the Option Securit